UNSPSC 51241710: Hydroxyethyl cellulose/polyvinyl alcohol/tyloxapol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP400. This VA Drug Class (OP400) classifies this compound as belonging to the group CONTACT LENS SOLUTIONS.

UNSPSC 51241710 Hydroxyethyl cellulose/polyvinyl alcohol/tyloxapol is a Commodity code covering specialized pharmaceutical excipient and ophthalmic products that state and local governments procure as components of broader generic and over-the-counter pharmaceutical supply agreements. State and local buyers source this code primarily through cooperative purchasing vehicles and multi-agency pharmaceutical contracts rather than direct commodity solicitations. Issuing bodies include state procurement offices administering multistate cooperative agreements, state health and human services departments, and participating municipalities and counties accessing those frameworks. The work involves establishing vendor relationships for consistent supply of pharmaceutical-grade formulations meeting FDA compliance, current Good Manufacturing Practices (cGMP), and Drug Supply Chain Security Act (DSCSA) certification, with vendors required to maintain distribution agreements with authorized pharmaceutical wholesalers and meet detailed product specification and shelf-life requirements.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued the primary recent opportunity—a Request for Proposal (RFP) for Generic Multi-Source Pharmaceuticals and OTC Products posted January 20, 2026, with a response due date of March 26, 2026. The solicitation establishes multiple contracts distributing across participating state and local government facilities in Minnesota and Oregon, with awarded vendors required to provide products through three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) beginning July 1, 2026. Vendors must certify cGMP and DSCSA compliance, maintain relationships with at least two of the three designated wholesalers with chargeback systems in place, and submit detailed product information including National Drug Code (NDC), SKU, UPC, dosage form, strength, and manufacturing location, with pricing weighted at 75 percent of evaluation criteria. The contract term is two years for new responders, with optional extensions at MMCAP's discretion, and vendors must carry commercial general liability of $5,000,000 per occurrence and network security and privacy liability of $2,000,000.